Literature DB >> 2145898

Effects of prostaglandin and leukotriene inhibitors on the growth of human glioma spheroids.

I Gàti1, M Bergström, G Westerberg, K Csòka, C Muhr, J Carlsson.   

Abstract

Established cell-lines of human glioma origin were cultured as multicellular spheroids or as monolayers. Volume growth and 3H-thymidine labelling were analysed for the spheroids after continuous exposure to drugs interfering with the release of arachidonic acid and the production of prostaglandins and leukotrienes. Comparative measurements were made on monolayer cultures. The cyclo-oxygenase inhibitor indomethacin enhanced growth at intermediate concentrations (0.5-5.0 micrograms/ml) but reduced growth at 50 micrograms/ml. The dual cyclo-oxygenase and lipoxygenase inhibitor ketoprofen had a significant inhibitory effect on growth and cell proliferation of spheroids at high concentration (50 micrograms/ml). The weak lipoxygenase inhibitor NDGA (quinone-form) decreased growth whereas the strong lipoxygenase inhibitor NDGA (hydroquinone-form) did not reduce growth rate but significantly decreased cell proliferation. Quinacrine reduced the spheroid growth rate although dexamethasone had no effects. Thus, inhibitors of the arachidonic acid cascade had growth inhibitory effects in the spheroid tumour model as well as in cells cultured as monolayers.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145898     DOI: 10.1016/0277-5379(90)90156-n

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  4 in total

1.  Ketoprofen-loaded polymeric nanocapsules selectively inhibit cancer cell growth in vitro and in preclinical model of glioblastoma multiforme.

Authors:  Elita F da Silveira; Janaine M Chassot; Fernanda C Teixeira; Juliana H Azambuja; Gabriela Debom; Fátima T Beira; Francisco A B Del Pino; Adriana Lourenço; Ana P Horn; Letícia Cruz; Roselia M Spanevello; Elizandra Braganhol
Journal:  Invest New Drugs       Date:  2013-09-27       Impact factor: 3.850

2.  A new, fast and semi-automated size determination method (SASDM) for studying multicellular tumor spheroids.

Authors:  Azita Monazzam; Pasha Razifar; Orjan Lindhe; Raymond Josephsson; Bengt Långström; Mats Bergström
Journal:  Cancer Cell Int       Date:  2005-11-14       Impact factor: 5.722

Review 3.  A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.

Authors:  Richard E Kast; John A Boockvar; Ansgar Brüning; Francesco Cappello; Wen-Wei Chang; Boris Cvek; Q Ping Dou; Alfonso Duenas-Gonzalez; Thomas Efferth; Daniele Focosi; Seyed H Ghaffari; Georg Karpel-Massler; Kirsi Ketola; Alireza Khoshnevisan; Daniel Keizman; Nicolas Magné; Christine Marosi; Kerrie McDonald; Miguel Muñoz; Ameya Paranjpe; Mohammad H Pourgholami; Iacopo Sardi; Avishay Sella; Kalkunte S Srivenugopal; Marco Tuccori; Weiguang Wang; Christian R Wirtz; Marc-Eric Halatsch
Journal:  Oncotarget       Date:  2013-04

4.  Multicellular tumour spheroid as a model for evaluation of [18F]FDG as biomarker for breast cancer treatment monitoring.

Authors:  Azita Monazzam; Pasha Razifar; Martin Simonsson; Fredrik Qvarnström; Raymond Josephsson; Carl Blomqvist; Bengt Långström; Mats Bergström
Journal:  Cancer Cell Int       Date:  2006-03-23       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.